Figure 11.1

ESRD spending, by payor
[Download]

Figure 11.2

Costs of the Medicare & ESRD programs
[Download]

Figure 11.3

Estimated numbers of point prevalent ESRD patients
[Download]

Figure 11.4

Annual percent change in Medicare ESRD spending
[Download]

Figure 11.5

Total Medicare dollars spent on ESRD, by type of service
[Download]

Figure 11.6

Total Medicare ESRD expenditures, by modality
[Download]

Figure 11.7

Total Medicare ESRD expenditures per person per year, by modality
[Download]

Figure 11.8

Per person per year inpatient/outpatient & physician/supplier net costs for Medicare & MarketScan (EGHP) patients with ESRD
[Download]

Figure 11.9

Total Medicare spending for injectables
[Download]

Figure 11.10

Per person per year costs for injectables, 2009
[Download]

Figure 11.11

Unadjusted per person per year costs (dollars) for injectables, by HSA, 2009
[Download]

Figure 11.12

Total per person per year outpatient expenditures, by race
[Download]

Figure 11.13

Per person per year expenditures for laboratory tests, by race
[Download]

Figure 11.14

Per person per year expenditures for ESAs, by race
[Download]

Figure 11.15

Per person per year expenditures for IV vitamin D, by race
[Download]

Figure 11.16

Per person per year expenditures for IV iron, by race
[Download]

Figure 11.17

Per person per year expenditures for IV antibiotics, by race
[Download]

Figure 11.18

Per person per year expenditures for other injectables, by race
[Download]

Figure 11.19

Total per person per year outpatient expenditures, by dialysis modality & race, 2009
[Download]

Figure 11.20

PPPY expenditures for laboratory tests, by dialysis modality & race, 2009
[Download]

Figure 11.21

PPPY expenditures for ESAs, by dialysis modality & race, 2009
[Download]

Figure 11.22

PPPY expenditures for IV vitamin D, by dialysis modality & race, 2009
[Download]

Figure 11.23

PPPY expenditures for IV iron, by dialysis modality & race, 2009
[Download]

Figure 11.24

PPPY expenditures for IV antibiotics, by dialysis modality & race, 2009
[Download]

Figure 11.25

PPPY expenditures for other injectables, by dialysis modality & race, 2009
[Download]

Figure 11.28

Total Part D net costs, by low income subsidy (LIS) status, 2008
[Download]

Figure 11.29

Per person per year (PPPY) Part D net costs, by LIS status, 2008
[Download]

Figure 11.30

PPPY out-of-pocket Part D costs, by LIS status, 2008
[Download]

Figure 11.31

PPPY Part D net costs for anti-hypertensives, by LIS status, 2008
[Download]

Figure 11.32

PPPY Part D net $ for antihypertensives in dialysis pts, by LIS status & race, 2008
[Download]

Figure 11.33

PPPY Part D net costs for diabetes agents, by LIS status, 2008
[Download]

Figure 11.34

PPPY Part D net costs for diabetes agents in dialysis pts, by LIS status & race, 2008
[Download]

Figure 11.35

PPPY Part D net $ for cinacalcet in dialysis patients, by LIS status & race, 2008
[Download]

Figure 11.36

PPPY Part D net $ for phosphate binders in dialysis pts, by LIS status & race, 2008
[Download]

Table A

Top 25 drugs used in Part D-enrolled ESRD patients, by frequency & net cost, 2008
[Download]